Parkinson's Disease: Difference between revisions
Jump to navigation
Jump to search
Created page with " Parkinson’s disease is an idiopathic and has no known cause. It is normally due to the degeneration of dopaminergic neurones of the nigrostriatal tract and loss of DA neu..." |
No edit summary |
||
| Line 1: | Line 1: | ||
Parkinson’s disease is an idiopathic and has no known cause. It is normally due to the degeneration of dopaminergic neurones of the nigrostriatal tract and loss of DA neurotransmission in the striatum. The symptoms of this disease are a resting tremor, muscle rigidity and suppression of voluntary movements (hypokinesis). | Parkinson’s disease is an idiopathic and has no known cause. It is normally due to the degeneration of dopaminergic neurones of the nigrostriatal tract and loss of DA neurotransmission in the striatum. The symptoms of this disease are a resting tremor, muscle rigidity and suppression of voluntary movements (hypokinesis). | ||
<br>The main 4 dopaminergic pathways are:- | <br>The main 4 dopaminergic pathways are:- | ||
<br>• Nigrostriatal<br>– Substantia nigra to striatum | <br>• Nigrostriatal<br>– Substantia nigra to [[striatum|striatum]] | ||
<br>• Mesolimbic<br>– Ventral tegmental area to nucleus accumbens | <br>• Mesolimbic<br>– Ventral tegmental area to nucleus accumbens | ||
<br>• Mesocortical<br>– Ventral tegmental area to frontal cortex | <br>• Mesocortical<br>– Ventral tegmental area to [[frontal cortex|frontal cortex]] | ||
<br>• Tuberoinfundibular<br>– Arcuate nucleus to pituitary gland | <br>• Tuberoinfundibular<br>– Arcuate nucleus to [[Pituitary_gland|pituitary gland]] | ||
<br>The decarboxylase inhibitor – carbidopa, the MAO inhibitor: Selegiline and D2 receptor agonists like Bromocriptine can be used to treat Parkinson’s disease. | <br>The decarboxylase inhibitor – carbidopa, the[[MAO|MAO inhibitor]]: Selegiline and [[D2 receptor|D2 receptor agonists]] like Bromocriptine can be used to treat Parkinson’s disease. | ||
Revision as of 17:02, 19 October 2013
Parkinson’s disease is an idiopathic and has no known cause. It is normally due to the degeneration of dopaminergic neurones of the nigrostriatal tract and loss of DA neurotransmission in the striatum. The symptoms of this disease are a resting tremor, muscle rigidity and suppression of voluntary movements (hypokinesis).
The main 4 dopaminergic pathways are:-
• Nigrostriatal
– Substantia nigra to striatum
• Mesolimbic
– Ventral tegmental area to nucleus accumbens
• Mesocortical
– Ventral tegmental area to frontal cortex
• Tuberoinfundibular
– Arcuate nucleus to pituitary gland
The decarboxylase inhibitor – carbidopa, theMAO inhibitor: Selegiline and D2 receptor agonists like Bromocriptine can be used to treat Parkinson’s disease.